Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study by Marcellin, Patrick, Prof, Gane, Edward, Prof, Buti, Maria, Prof, Afdhal, Nezam, Prof, Sievert, William, Prof, Jacobson, Ira M, Prof, Washington, Mary Kay, Prof, Germanidis, George, Prof, Flaherty, John F, PharmD, Schall, Raul Aguilar, PhD, Bornstein, Jeffrey D, MD, Kitrinos, Kathryn M, PhD, Subramanian, G Mani, MD, McHutchison, John G, MD, Heathcote, E Jenny, Prof

Get full text

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR... by Lawitz, Eric, Prof, Poordad, Fred F, Prof, Pang, Phillip S, MD, Hyland, Robert H, DPhil, Ding, Xiao, PhD, Mo, Hongmei, PhD, Symonds, William T, PharmD, McHutchison, John G, MD, Membreno, Fernando E, MD

Get full text

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, d... by Bourlière, Marc, Dr, Bronowicki, Jean-Pierre, MD, de Ledinghen, Victor, MD, Hézode, Christophe, MD, Zoulim, Fabien, MD, Mathurin, Philippe, MD, Tran, Albert, MD, Larrey, Dominique G, MD, Ratziu, Vlad, MD, Alric, Laurent, MD, Hyland, Robert H, DPhil, Jiang, Deyuan, PhD, Doehle, Brian, PhD, Pang, Phillip S, MD, Symonds, William T, PharmD, Subramanian, G Mani, MD, McHutchison, John G, MD, Marcellin, Patrick, MD, Habersetzer, François, MD, Guyader, Dominique, MD, Grangé, Jean-Didier, MD, Loustaud-Ratti, Véronique, MD, Serfaty, Lawrence, MD, Metivier, Sophie, MD, Leroy, Vincent, MD, Abergel, Armand, MD, Pol, Stanislas, MD

Get full text

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 tri... by Manns, Michael, Prof, Samuel, Didier, Prof, Gane, Edward J, Prof, Mutimer, David, Prof, McCaughan, Geoff, Prof, Buti, Maria, Prof, Prieto, MartÍn, MD, Calleja, José Luis, MD, Peck-Radosavljevic, Markus, Prof, Müllhaupt, Beat, Prof, Agarwal, Kosh, MD, Angus, Peter, Prof, Yoshida, Eric M, MD, Colombo, Massimo, Prof, Rizzetto, Mario, Prof, Dvory-Sobol, Hadas, PhD, Denning, Jill, MA, Arterburn, Sarah, MS, Pang, Phillip S, MD, Brainard, Diana, MD, McHutchison, John G, MD, Dufour, Jean-François, MD, Van Vlierberghe, Hans, Prof, van Hoek, Bart, Prof, Forns, Xavier, MD

Get full text

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study by Molina, Jean-Michel, Prof, Orkin, Chloe, MD, Iser, David M, MBBS, Zamora, Francisco-Xavier, MD, Nelson, Mark, MBBS, Stephan, Christoph, Prof, Massetto, Benedetta, MD, Gaggar, Anuj, MD, Ni, Liyun, MA, Svarovskaia, Evguenia, PhD, Brainard, Diana, MD, Subramanian, G Mani, MD, McHutchison, John G, MD, Puoti, Massimo, Prof, Rockstroh, Jürgen K, Prof

Get full text

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an... by Mizokami, Masashi, Prof, Yokosuka, Osamu, Prof, Takehara, Tetsuo, Prof, Sakamoto, Naoya, Prof, Korenaga, Masaaki, MD, Mochizuki, Hitoshi, MD, Nakane, Kunio, MD, Enomoto, Hirayuki, MD, Ikeda, Fusao, MD, Yanase, Mikio, MD, Toyoda, Hidenori, MD, Genda, Takuya, MD, Umemura, Takeji, MD, Yatsuhashi, Hiroshi, Prof, Ide, Tatsuya, MD, Toda, Nobuo, MD, Nirei, Kazushige, Ueno, Yoshiyuki, Prof, Nishigaki, Yoichi, MD, Betular, Juan, BS, Gao, Bing, PhD, Ishizaki, Akinobu, BA, Omote, Masa, PhD, Mo, Hongmei, MD, Garrison, Kim, PhD, Pang, Phillip S, MD, Knox, Steven J, BS, Symonds, William T, PharmD, McHutchison, John G, MD, Izumi, Namiki, Prof, Omata, Masao, Prof

Get full text

Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response by Gellad, Ziad F., MD, MPH, Muir, Andrew J., MD, MHS, McHutchison, John G., MD, Sievert, William, MD, Sharara, Ala I., MD, Brown, Kimberly A., MD, Flisiak, Robert, MD, Jacobson, Ira M., MD, Kershenobich, David, MD, Manns, Michael P., MD, Schulman, Kevin A., MD, Reed, Shelby D., PhD

Get full text

Current therapies for chronic hepatitis C: Drug combination achieves sustained response in more than half of patients by Patel, Keyur, McHutchison, John G.

Get full text

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study by Kohli, Anita, MD, Osinusi, Anuoluwapo, MD, Sims, Zayani, BS, Nelson, Amy, RN, Meissner, Eric G, MD, Barrett, Lisa L, MD, Bon, Dimitra, MS, Marti, Miriam M, BS, Silk, Rachel, RN, Kotb, Colleen, NP, Gross, Chloe, RN, Jolley, Tim A, RN, Sidharthan, Sreetha, BS, Petersen, Tess, BS, Townsend, Kerry, BA, Egerson, D'Andrea, RN, Kapoor, Rama, MD, Spurlin, Emily, BA, Sneller, Michael, MD, Proschan, Michael, PhD, Herrmann, Eva, PhD, Kwan, Richard, PAC, Teferi, Gebeyehu, MD, Talwani, Rohit, MD, Diaz, Gabbie, RN, Kleiner, David E, MD, Wood, Brad J, MD, Chavez, Jose, MD, Abbott, Stephen, MD, Symonds, William T, PharmD, Subramanian, G Mani, MD, Pang, Phillip S, MD, McHutchison, John, MD, Polis, Michael A, MD, Fauci, Anthony S, MD, Masur, Henry, MD, Kottilil, Shyam, Dr

Get full text